TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tarpoon Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
83
|
76
|
123 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
74
|
46
|
23 |
| EBITDA |
72
|
44
|
21 |
| Total assets |
339
|
297
|
283 |
| Current assets |
78
|
101
|
87 |
| Current liabilities |
15
|
9
|
21 |
| Equity capital |
306
|
274
|
249 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.3%
|
92.3%
|
88.0% |
| Turnover per employee |
83
|
76
|
123 |
| Profit as a percentage of turnover |
89.2%
|
60.5%
|
18.7% |
| Return on assets (ROA) |
21.8%
|
15.5%
|
8.1% |
| Current ratio |
520.0%
|
1122.2%
|
414.3% |
| Return on equity (ROE) |
24.2%
|
16.8%
|
9.2% |
| Change turnover |
10
|
-48
|
-1 |
| Change turnover % |
13%
|
-39%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.